Literature DB >> 27048353

Pharmacologic Treatment of Pediatric Hypertension.

Rachita S Dhull1, Rossana Baracco1, Amrish Jain1, Tej K Mattoo2.   

Abstract

Prevalence of hypertension is increasing in children and adolescents. Uncontrolled hypertension in children not only causes end organ damage but also increases the risk of adult hypertension and cardiovascular disease. Clinical trials have proven efficacy of antihypertensive medications in children. These medications are well tolerated by children with acceptable safety profile. The choice of agent is usually driven by underlying etiology of hypertension, profile of its side effects, and clinician's preference. This article will review currently available pediatric data on mechanism of action, common adverse effects, pediatric indication, recent clinical trial, and newer drugs in the common classes of antihypertensive medications.

Entities:  

Keywords:  Clinical trials; Dosing for hypertension; Hypertension; Hypertension in children; Pharmacologic management

Mesh:

Substances:

Year:  2016        PMID: 27048353     DOI: 10.1007/s11906-016-0639-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  47 in total

1.  Racial differences are seen in blood pressure response to fosinopril in hypertensive children.

Authors:  Sharad Menon; Katherine Y Berezny; Rakhi Kilaru; Daniel K Benjamin; Joseph D Kay; Lydie Hazan; Ronald Portman; Ronald Hogg; David Deitchman; Robert M Califf; Jennifer S Li
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

2.  A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension.

Authors:  Lydie Hazan; Oscar A Hernández Rodriguez; As'ad E Bhorat; Koichi Miyazaki; Ben Tao; Reinilde Heyrman
Journal:  Hypertension       Date:  2010-04-12       Impact factor: 10.190

3.  Use of calcium-channel blockers in pediatric renal transplant recipients.

Authors:  D M Silverstein; J Palmer; H J Baluarte; C Brass; S B Conley; M S Polinsky
Journal:  Pediatr Transplant       Date:  1999-11

4.  Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials.

Authors:  C M Baker-Smith; D K Benjamin; R M Califf; M D Murphy; J S Li; P B Smith
Journal:  Clin Pharmacol Ther       Date:  2010-02-03       Impact factor: 6.875

5.  A double-blind, dose-response study of losartan in hypertensive children.

Authors:  Shahnaz Shahinfar; Francisco Cano; Beth A Soffer; Tuli Ahmed; Emanuela P Santoro; Zhongxin Zhang; Gilbert Gleim; Kenneth Miller; Beth Vogt; Jeffrey Blumer; Igor Briazgounov
Journal:  Am J Hypertens       Date:  2005-02       Impact factor: 2.689

6.  Randomized, double-blind, controlled study of losartan in children with proteinuria.

Authors:  Nicholas J A Webb; Chun Lam; Tom Loeys; Shahnaz Shahinfar; Juergen Strehlau; Thomas G Wells; Emanuela Santoro; Denise Manas; Gilbert W Gleim
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

7.  Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?

Authors:  Jennifer S Li; Katherine Berezny; Rakhi Kilaru; Lydie Hazan; Ronald Portman; Ronald Hogg; Randall D Jenkins; Prapti Kanani; Carol M Cottrill; Tej K Mattoo; Ludmila Zharkova; Ludmila Kozlova; Irit Weisman; David Deitchman; Robert M Califf
Journal:  Hypertension       Date:  2004-07-19       Impact factor: 10.190

8.  Strict blood-pressure control and progression of renal failure in children.

Authors:  Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 9.  Safety of the newer antihypertensive agents in children.

Authors:  Douglas L Blowey
Journal:  Expert Opin Drug Saf       Date:  2002-05       Impact factor: 4.250

Review 10.  Hypertension in children and adolescents: epidemiology and natural history.

Authors:  Bonita Falkner
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

View more
  3 in total

Review 1.  Treatment Strategies for Paradoxical Hypertension Following Surgical Correction of Coarctation of the Aorta in Children.

Authors:  Peter P Roeleveld; Eline G Zwijsen
Journal:  World J Pediatr Congenit Heart Surg       Date:  2017-05

2.  The intake assessment of diverse dietary patterns on childhood hypertension: alleviating the blood pressure and lipidemic factors with low-sodium seafood rich in omega-3 fatty acids.

Authors:  Anahita Izadi; Leila Khedmat; Reza Tavakolizadeh; Sayed Yousef Mojtahedi
Journal:  Lipids Health Dis       Date:  2020-04-07       Impact factor: 3.876

3.  Mission-based cardiac surgery and catheter treatment of coarctation of aorta in the young and older children: a facility based review of cases in Addis Ababa.

Authors:  Kalkidan Gebremeskel Woldmichael; Tamirat Moges Aklilu
Journal:  Pan Afr Med J       Date:  2019-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.